Case Reports

An unusual case of non-small-cell lung cancer presenting as spontaneous cardiac tamponade


 

Hemorrhagic pericardial effusion with associated cardiac tamponade as a de novo sign of malignancy is seen in about 2% of patients.1 Consequently, cardiac tamponade is an oncologic emergency and considered a unique presentation of a malignancy.2 Cancer emergency is defined as an acute condition that is caused directly by the cancer itself or its treatment and requires intervention to avoid death or significant morbidity.3 The mechanism by which cardiac tamponade is classified as a life-threatening emergency stems from its impairment of right ventricular filling, resulting in ventricular diastolic collapse and decreased cardiac output, which can ultimately lead to death.4

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Wanted: Better evidence on fast-track lung resection
MDedge Hematology and Oncology
Does sharing genetic risk change behavior?
MDedge Hematology and Oncology
CT of chest, extremity effective for sarcoma follow-up
MDedge Hematology and Oncology
Impact of trimodality treatment on patient quality of life and arm function for superior sulcus tumors
MDedge Hematology and Oncology
An uncommon presentation of non-small-cell lung cancer with acrometastases to the great toe and index finger
MDedge Hematology and Oncology
Crizotinib bests chemo at controlling brain metastases in advanced NSCLC
MDedge Hematology and Oncology
Gefitinib missed noninferiority endpoint vs. erlotinib in lung cancer trial
MDedge Hematology and Oncology
Feds advance cancer moonshot with expert panel, outline of goals
MDedge Hematology and Oncology
FDA grants priority review for additional use of atezolizumab
MDedge Hematology and Oncology
Targeting gene rearrangements shows promise in early study
MDedge Hematology and Oncology